SFP
GILD icon

Sterling Financial Planning’s Gilead Sciences GILD Stock Holding History

Sterling Financial Planning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-600
Closed -$42K – 218
2021
Q3 		$42K Hold
600
– – 0.03% 196
2021
Q2 		$41K Hold
600
– – 0.03% 186
2021
Q1 		$39K Sell
600
-300
-33% -$19.3K 0.03% 169
2020
Q4 		$52K Buy
+900
New +$54.3K 0.04% 139

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sterling Financial Planning's GILD Position: Q4 2021 in Review

Sterling Financial Planning sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 600 shares — an estimated $42K sold.

Sterling Financial Planning first reported a position in GILD in Q4 2020 and held it in 4 quarters. The position peaked at $52K in Q4 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Sterling Financial Planning reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Sterling Financial Planning sold 600 Gilead Sciences shares in Q4 2021, an estimated $42K.
  • Sterling Financial Planning first reported a position in Gilead Sciences in Q4 2020 and held it in 4 quarters.
  • Sterling Financial Planning's Gilead Sciences position peaked at $52K in Q4 2020.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Sterling Financial Planning's 13F filing for Q4 2021, filed 2 Feb 2022.